FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Foung

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Genes & Molecular Sequences

Amino Acid Sequences

Anatomy

Concepts & Ideas

Molecular Sequence Data

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
Thomas H R Carlsen; Steven K H Foung; Santseharay Ramirez; Troels K H Scheel; Jens Bukh
Characterization of hepatitis C virus recombinants with chimeric E1/E2 envelope proteins and identification of single amino acids in the E2 stem region important for entry.
Zhen-Yong Keck; Patrick Lau; Arvind H Patel; Jannick Prentoe; Wenyan Wang; Yong Wang; Jinming Xia; Jens Bukh; Thomas H R Carlsen; Steven K H Foung
Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein.
Zhe Liu; Guangxiang Luo; Keigo Machida; Steven K H Foung; Michael M C Lai; Yongjun Tian; Jing-hsiung James Ou
Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Foung (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Thomas H R Carlsen; Steven K H Foung; Santseharay Ramirez; Troels K H Scheel; Jens Bukh
Characterization of hepatitis C virus recombinants with chimeric E1/E2 envelope proteins and identification of single amino acids in the E2 stem region important for entry.
Journal of virology 2013;87(3):1385-99.
2013: Zhen-Yong Keck; Patrick Lau; Arvind H Patel; Jannick Prentoe; Wenyan Wang; Yong Wang; Jinming Xia; Jens Bukh; Thomas H R Carlsen; Steven K H Foung
Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein.
Journal of virology 2013;87(1):37-51.
2012: Zhe Liu; Guangxiang Luo; Keigo Machida; Steven K H Foung; Michael M C Lai; Yongjun Tian; Jing-hsiung James Ou
Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry.
The Journal of biological chemistry 2012;287(50):41922-30.
2012: Jane A Potter; Garry L Taylor; Steven K H Foung; Nathan Jeffery; Zhen-Yong Keck; Patrick Lau; David J Matthews; Ania M Owsianka; Arvind H Patel
Toward a hepatitis C virus vaccine: the structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody.
Journal of virology 2012;86(23):12923-32.
2012: Isabel Fofana; Steven K H Foung; F Habersetzer; Juliette Hayer; Laura Heydmann; Marie-Sophie Hiet; Zhen-Yong Keck; Thomas Pietschmann; Françoise Stoll-Keller; Marine Turek; Muhammad Nauman Zahid; Mirjam B Zeisel; Patric Carolla; Christophe Combet; François-Loïc Cosset; Karine Cury; Michel Doffoël; Samira Fafi-Kremer; Catherine Fauvelle; Ralf Bartenschlager; Thomas F Baumert
Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies.
Gastroenterology 2012;143(1):223-233.e9.
2012: Zhen-Yong Keck; Thomas Krey; Stanley M Lemon; Angela Ying-Jian Li; Arvind H Patel; Jannick Prentoe; Felix A Rey; Wenyan Wang; Yong Wang; Jinming Xia; Jens Bukh; Thomas Carlsen; Steven K H Foung
Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate.
PLoS pathogens 2012;8(4):e1002653.
2011: Zhen-Yong Keck; Thomas Krey; Patrick Lau; Felix A Rey; Anasuya Saha; Yong Wang; Jinming Xia; Steven K H Foung
Mapping a region of hepatitis C virus E2 that is responsible for escape from neutralizing antibodies and a core CD81-binding region that does not tolerate neutralization escape mutations.
Journal of virology 2011;85(20):10451-63.
2011: Malgorzata Rychlowska; Krystyna Bienkowska-Szewczyk; Jean Dubuisson; Steven K H Foung; Ania M Owsianka; Arvind H Patel
Comprehensive linker-scanning mutagenesis of the hepatitis C virus E1 and E2 envelope glycoproteins reveals new structure-function relationships.
The Journal of general virology 2011;92(Pt 10):2249-61.
2011: Alessia Bianchi; Michela Brazzoli; Stefania Crotta; Steven K H Foung; Marcello Merola
Hepatitis C virus e2 protein ectodomain is essential for assembly of infectious virions.
International journal of hepatology 2011;2011():968161.
2011: Valentina Botti; Steven K H Foung; Alessia Bianchi; Marcello Merola
The hepatitis C virus E1 glycoprotein undergoes productive folding but accelerated degradation when expressed as an individual subunit in CHO cells.
PloS one 2011;6(8):e23838.
2010: Dorothea Bankwitz; Eike Steinmann; Julia Bitzegeio; Sandra Ciesek; Martina Friesland; Eva Herrmann; Mirjam B Zeisel; Thomas F Baumert; Zhen-yong Keck; Steven K H Foung; Eve-Isabelle Pécheur; Thomas Pietschmann
Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.
Journal of virology 2010;84(11):5751-63.
2010: Simrat Dhillon; Jeroen Witteveldt; Derek Gatherer; Ania M Owsianka; Mirjam B Zeisel; Muhammad N Zahid; Malgorzata Rychłowska; Steven K H Foung; Thomas F Baumert; Allan G N Angus; Arvind H Patel
Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies.
Journal of virology 2010;84(11):5494-507.
2009: Gopal Sapparapu; Stephanie A Planque; Yasuhiro Nishiyama; Steven K H Foung; Sudhir Paul
Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.
The Journal of biological chemistry 2009;284(36):24622-33.
2009: Zhen-Yong Keck; Sophia H Li; Jinming Xia; Thomas von Hahn; Peter Balfe; Jane A McKeating; Jeroen Witteveldt; Arvind H Patel; Harvey Alter; Charles M Rice; Steven K H Foung
Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.
Journal of virology 2009;83(12):6149-60.
2008: Meital Gal-Tanamy; Zhen-Yong Keck; MinKyung Yi; Jane A McKeating; Arvind H Patel; Steven K H Foung; Stanley M Lemon
In vitro selection of a neutralization-resistant hepatitis C virus escape mutant.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(49):19450-5.
2008: Keigo Machida; Yasuteru Kondo; Jeffrey Y Huang; Yung-Chia Chen; Kevin T-H Cheng; Zhenyong Keck; Steven K H Foung; Jean Dubuisson; Vicky M-H Sung; Michael M C Lai
Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein.
Journal of virology 2008;82(13):6711-20.
2008: Zhen-Yong Keck; Ta-Kai Li; Jinming Xia; Meital Gal-Tanamy; Oakley Olson; Sophia H Li; Arvind H Patel; Jonathan K Ball; Stanley M Lemon; Steven K H Foung
Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies.
Journal of virology 2008;82(12):6061-6.
2008: Zhen-Yong Keck; Oakley Olson; Meital Gal-Tanamy; Jinming Xia; Arvind H Patel; Marlène Dreux; François-Loïc Cosset; Stanley M Lemon; Steven K H Foung
A point mutation leading to hepatitis C virus escape from neutralization by a monoclonal antibody to a conserved conformational epitope.
Journal of virology 2008;82(12):6067-72.
2008: Ania M Owsianka; Alexander W Tarr; Zhen-Yong Keck; Ta-Kai Li; Jeroen Witteveldt; Richard Adair; Steven K H Foung; Jonathan K Ball; Arvind H Patel
Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein.
The Journal of general virology 2008;89(Pt 3):653-9.
2008: Roxana E Iacob; Zhenyong Keck; Oakley Olson; Steven K H Foung; Kenneth B Tomer
Structural elucidation of critical residues involved in binding of human monoclonal antibodies to hepatitis C virus E2 envelope glycoprotein.
Biochimica et biophysica acta 2008;1784(3):530-42.
2008: Keith Meyer; Malika Ait-Goughoulte; Zhen-Yong Keck; Steven K H Foung; Ranjit Ray
Antibody-dependent enhancement of hepatitis C virus infection.
Journal of virology 2008;82(5):2140-9.
2008: Zhen-Yong Keck; K Machida; Michael M C Lai; Jonathan K Ball; Arvind H Patel; Steven K H Foung
Therapeutic control of hepatitis C virus: the role of neutralizing monoclonal antibodies.
Current topics in microbiology and immunology 2008;317():1-38.
2007: François Helle; Anne Goffard; Virginie Morel; Gilles Duverlie; Jane A McKeating; Zhen-Yong Keck; Steven K H Foung; François Penin; Jean Dubuisson; Cécile Voisset
The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein.
Journal of virology 2007;81(15):8101-11.
2007: Zhen-Yong Keck; Jinming Xia; Zhaohui Cai; Ta-Kai Li; Ania M Owsianka; Arvind H Patel; Guangxiang Luo; Steven K H Foung
Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions.
Journal of virology 2007;81(2):1043-7.
2006: Marlène Dreux; Thomas Pietschmann; Christelle Granier; Cécile Voisset; Sylvie Ricard-Blum; Philippe-Emmanuel Mangeot; Zhen-Yong Keck; Steven K H Foung; Ngoc Vu-Dac; Jean Dubuisson; Ralf Bartenschlager; Dimitri Lavillette; François-Loïc Cosset
High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.
The Journal of biological chemistry 2006;281(27):18285-95.
2006: Rachel Eren; Dorit Landstein; Dov Terkieltaub; Ofer Nussbaum; Arie Zauberman; Judith Ben-Porath; Judith Gopher; Rachel Buchnick; Riva Kovjazin; Ziva Rosenthal-Galili; Sigal Aviel; Ehud Ilan; Yariv Shoshany; Lewis F Neville; Tal Waisman; Ofer Ben-Moshe; Alberto Kischitsky; Steven K H Foung; Zhen-Yong Keck; Orit Pappo; Ahmed Eid; Oded Jurim; Gideon Zamir; Eithan Galun; Shlomo Dagan
Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients.
Journal of virology 2006;80(6):2654-64.
2006: Keigo Machida; Kevin T-H Cheng; Vicky M-H Sung; Alexandra M Levine; Steven K H Foung; Michael M C Lai
Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6.
Journal of virology 2006;80(2):866-74.
2005: Zhen-Yong Keck; Ta-Kai Li; Jinming Xia; Birke Bartosch; François-Loïc Cosset; Jean Dubuisson; Steven K H Foung
Analysis of a highly flexible conformational immunogenic domain a in hepatitis C virus E2.
Journal of virology 2005;79(21):13199-208.
2005: Michela Brazzoli; ari Helenius; Steven K H Foung; Michael Houghton; Sergio Abrignani; Marcello Merola
Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells.
Virology 2005;332(1):438-53.
2004: Hiroaki Taguchi; Zhen-Yong Keck; Steven K H Foung; Sudhir Paul; Yasuhiro Nishiyama
Antibody light chain-catalyzed hydrolysis of a hepatitis C virus peptide.
Bioorganic & medicinal chemistry letters 2004;14(17):4529-32.
2004: Zhen-Yong Keck; Anne Op De Beeck; Kenneth G Hadlock; Jinming Xia; Ta-Kai Li; Jean Dubuisson; Steven K H Foung
Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions.
Journal of virology 2004;78(17):9224-32.
2004: Tae-Hwe Heo; Jae-Hoon Chang; Jae-Woo Lee; Steven K H Foung; Jean Dubuisson; Chang-Yuil Kang
Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of putative multiple receptors by E2 envelope glycoprotein.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(1):446-55.
2004: Zhen-Yong Keck; Vicky M-H Sung; Susan Perkins; Judy Rowe; Sudhir Paul; TSANYANG LIANG; Michael M C Lai; Steven K H Foung
Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity.
Journal of virology 2004;78(13):7257-63.
2004: Anne Op De Beeck; Cécile Voisset; Birke Bartosch; Yann Ciczora; Laurence Cocquerel; Zhen-Yong Keck; Steven K H Foung; François-Loïc Cosset; Jean Dubuisson
Characterization of functional hepatitis C virus envelope glycoproteins.
Journal of virology 2004;78(6):2994-3002.
2003: Pierre-Yves Lozach; Hugues Lortat-Jacob; Agnès de Lacroix de Lavalette; Isabelle Staropoli; Steven K H Foung; Ali Amara; Corinne Houles; Franck Fieschi; Olivier Schwartz; Jean-Louis Virelizier; Fernando Arenzana-Seisdedos; Ralf Altmeyer
DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2.
The Journal of biological chemistry 2003;278(22):20358-66.
2003: Laurence Cocquerel; Elizabeth Quinn; Mike Flint; Kenneth G Hadlock; Steven K H Foung; Shoshana Levy
Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody.
Journal of virology 2003;77(2):1604-9.
2002: Miriam Triyatni; John Vergalla; Anthony R Davis; Kenneth G Hadlock; Steven K H Foung; TSANYANG LIANG
Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.
Virology 2002;298(1):124-32.
2002: Kenneth G Hadlock; Qing Yang; Judy Rowe; Steven K H Foung
Epitope mapping of human monoclonal antibodies recognizing conformational epitopes within HTLV type 1 gp46, employing HTLV type 1/2 envelope chimeras.
AIDS research and human retroviruses 2002;18(1):57-70.
2001: Elizabeth Quinn; C H Chan; Kenneth G Hadlock; Steven K H Foung; Mike Flint; Shoshana Levy
The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis.
Blood 2001;98(13):3745-9.
2001: Kenneth G Hadlock; R Gish; Judy Rowe; S S Rajyaguru; M Newsom; Ann Warford; Steven K H Foung
Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).
Journal of medical virology 2001;65(1):23-9.
2001: C H Chan; Kenneth G Hadlock; Steven K H Foung; Shoshana Levy
V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen.
Blood 2001;97(4):1023-6.
2000: Kenneth G Hadlock; Robert E Lanford; Susan Perkins; Judy Rowe; Qing Yang; Shoshana Levy; Piero Pileri; Sergio Abrignani; Steven K H Foung
Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes.
Journal of virology 2000;74(22):10407-16.
1999: Kenneth G Hadlock; Judy Rowe; Steven K H Foung
The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.
Journal of virology 1999;73(2):1205-12.
1998: TC Gentile; Kenneth G Hadlock; A H Uner; B Delal; E Squiers; S Crowley; R C Woodman; Steven K H Foung; Bernard J Poiesz; Thomas P Loughran
Large granular lymphocyte leukaemia occurring after renal transplantation.
British journal of haematology 1998;101(3):507-12.
1998: Thomas P Loughran; Kenneth G Hadlock; RN Perzova; TC Gentile; Qing Yang; Steven K H Foung; Bernard J Poiesz
Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia.
British journal of haematology 1998;101(2):318-24.
1998: Kenneth G Hadlock; Steven K H Foung
GBV-C/HGV: a new virus within the Flaviviridae and its clinical implications.
Transfusion medicine reviews 1998;12(2):94-108.
1997: Thomas P Loughran; Kenneth G Hadlock; Qing Yang; RN Perzova; Renato Zambello; G Semenzato; Steven K H Foung; Bernard J Poiesz
Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes.
Blood 1997;90(5):1977-81.
1997: Kenneth G Hadlock; Judy Rowe; Susan Perkins; P Bradshaw; G Y Song; C Cheng; J Yang; Ron Gascon; J Halmos; S M Rehman; Michael S McGrath; Steven K H Foung
Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.
Journal of virology 1997;71(8):5828-40.
1996: J Arp; MA LeVatte; Judy Rowe; S Perkins; E King; C Leystra-Lantz; Steven K H Foung; Gregory A Dekaban
A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.
Journal of virology 1996;70(11):7349-59.
1996: Jeffrey Linnen; J Wages; Z Y Zhang-Keck; Kirk Fry; K Z Krawczynski; Harvey Alter; E Koonin; M Gallagher; M Alter; S Hadziyannis; Peter Karayiannis; Kevin Fung; Y Nakatsuji; James Shih; L Young; M Piatak; C Hoover; J Fernandez; S Chen; J C Zou; T Morris; KC Hyams; S Ismay; Jeffrey D Lifson; Georg Hess; Steven K H Foung; Howard Thomas; D Bradley; H Margolis; JP Kim
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent.
Science (New York, N.Y.) 1996;271(5248):505-8.
1995: M Varma; Donna L Rudolph; M Knuchel; William Switzer; Kenneth G Hadlock; M Velligan; L Chan; Steven K H Foung; Renu B Lal
Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
Journal of clinical microbiology 1995;33(12):3239-44.
1995: Kenneth G Hadlock; C J Goh; P A Bradshaw; S Perkins; J Lo; Jonathan E Kaplan; R Khabbaz; Steven K H Foung
Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein.
Blood 1995;86(4):1392-9.
1995: S Perkins; Steven K H Foung
Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
Methods in molecular biology (Clifton, N.J.) 1995;48():295-307.
1994: P A Bradshaw; M R Duran-Guarino; S Perkins; J I Rowe; J Fernandez; Kirk Fry; G R Reyes; L Young; Steven K H Foung
Localization of antigenic sites on human cytomegalovirus virion structural proteins encoded by UL48 and UL56.
Virology 1994;205(1):321-8.
1993: Renu B Lal; J J Lipka; Steven K H Foung; Kenneth G Hadlock; G R Reyes; W P Carney
Human T lymphotropic virus type I/II in Lake Lindu Valley, Central Sulawesi, Indonesia.
Journal of acquired immune deficiency syndromes 1993;6(9):1067-8.
1993: William A Sheremata; William J Harrington; P A Bradshaw; Steven K H Foung; S P Raffanti; J R Berger; S Snodgrass; L Resnick; B J Poiesz
Association of '(tropical) ataxic neuropathy' with HTLV-II.
Virus research 1993;29(1):71-7.
1993: William J Harrington; William A Sheremata; Brian Hjelle; D K Dube; P Bradshaw; Steven K H Foung; S Snodgrass; G Toedter; Lisa Cabral; B Poiesz
Spastic ataxia associated with human T-cell lymphotropic virus type II infection.
Annals of neurology 1993;33(4):411-4.
1993: Renu B Lal; C Buckner; R F Khabbaz; Jonathan E Kaplan; G Reyes; Kenneth G Hadlock; J Lipka; Steven K H Foung; L Chan; J E Coligan
Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.
Clinical immunology and immunopathology 1993;67(1):40-9.
1993: BD Roberts; Steven K H Foung; J J Lipka; Jonathan E Kaplan; Kenneth G Hadlock; G R Reyes; L Chan; Walid Heneine; R F Khabbaz
Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.
Journal of clinical microbiology 1993;31(2):260-4.
1992: C Buckner; C R Roberts; Steven K H Foung; J Lipka; G R Reyes; Kenneth G Hadlock; L Chan; R A Gongora-Biachi; Brian Hjelle; Renu B Lal
Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populations.
The Journal of infectious diseases 1992;166(5):1160-3.
1992: Kenneth G Hadlock; J J Lipka; T P Chow; Steven K H Foung; G R Reyes
Cloning and analysis of a recombinant antigen containing an epitope specific for human T-cell lymphotropic virus type II.
Blood 1992;79(10):2789-96.
1992: Donna L Rudolph; J Yee; J Mone; Steven K H Foung; J J Lipka; G R Reyes; Kenneth G Hadlock; L Chan; Francios VILLINGER; Michael D Lairmore
Serologic confirmation of simian T-lymphotropic virus type I infection by using immunoassays developed for human T-lymphotropic virus antibody detection.
Journal of clinical microbiology 1992;30(4):858-61.
1991: J J Lipka; P Santiago; L Chan; G R Reyes; K P Samuel; William A Blattner; G M Shaw; Carl Hanson; J J Sninsky; Steven K H Foung
Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II.
The Journal of infectious diseases 1991;164(2):400-3.
1991: S Perkins; Ulrich Zimmermann; Steven K H Foung
Parameters to enhance human hybridoma formation with hypoosmolar electrofusion.
Human antibodies and hybridomas 1991;2(3):155-9.
1991: Lawrence Honig; J J Lipka; K Y Young; John H Weiss; Steven K H Foung
HTLV-I-associated myelopathy in a Californian: diagnosis by reactivity to a viral recombinant antigen.
Neurology 1991;41(3):448-50.
1991: J J Lipka; K K Young; S Y Kwok; G R Reyes; J J Sninsky; Steven K H Foung
Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals.
Vox sanguinis 1991;61(3):171-6.
1990: Ulrich Zimmermann; P Gessner; R Schnettler; S Perkins; Steven K H Foung
Efficient hybridization of mouse-human cell lines by means of hypo-osmolar electrofusion.
Journal of immunological methods 1990;134(1):43-50.
1990: Steven K H Foung; S Perkins; K Kafadar; P Gessner; Ulrich Zimmermann
Development of microfusion techniques to generate human hybridomas.
Journal of immunological methods 1990;134(1):35-42.
1990: S Kwok; J J Lipka; N McKinney; D E Kellogg; Bernard J Poiesz; Steven K H Foung; J J Sninsky
Low incidence of HTLV infections in random blood donors with indeterminate western blot patterns.
Transfusion 1990;30(6):491-4.
1989: Steven K H Foung; S Perkins; P Bradshaw; Judy Rowe; L B Rabin; G R Reyes; E T Lennette
Human monoclonal antibodies to human cytomegalovirus.
The Journal of infectious diseases 1989;159(3):436-43.
1989: Steven K H Foung; S Perkins
Electric field-induced cell fusion and human monoclonal antibodies.
Journal of immunological methods 1989;116(1):117-22.
1988: L Rodriguez; L Winn; Steven K H Foung
Initial identification and mapping of distinct Rh0 (D) epitopes.
Revue française de transfusion et immuno-hématologie 1988;31(2):223-31.
1987: Steven K H Foung; J A Blunt; P S Wu; P Ahearn; L C Winn; Edgar G Engleman; F Carl Grumet
Human monoclonal antibodies to Rh0(D).
Vox sanguinis 1987;53(1):44-7.
1986: Steven K H Foung; J Blunt; S Perkins; L Winn; F Carl Grumet
A human monoclonal antibody to rhG.
Vox sanguinis 1986;50(3):160-3.
1985: Steven K H Foung; S Perkins; C Koropchak; D M Fishwild; A E Wittek; E G Engleman; F Carl Grumet; Ann M Arvin
Human monoclonal antibodies neutralizing varicella-zoster virus.
The Journal of infectious diseases 1985;152(2):280-5.
1985: Steven K H Foung; S Perkins; W D McCallum; S Tom; E G Engleman; F Carl Grumet
A new approach to the diagnosis of active Rh0(D) immunization in passively immunized pregnant women.
Vox sanguinis 1985;49(3):206-10.
1985: A Raubitschek; G Senyk; J Larrick; G Lizak; Steven K H Foung
Human monoclonal antibodies against group A red blood cells.
Vox sanguinis 1985;48(5):305-8.
1984: Steven K H Foung; S Perkins; A Raubitschek; J Larrick; G Lizak; D Fishwild; E G Engleman; F Carl Grumet
Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Journal of immunological methods 1984;70(1):83-90.